|
|||||
|
|
Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding |
|
| Authors: | Serebruany Victor L O'Connor Christopher M Krishnan Ranga R Hennekens Charles H |
| Affiliation: | HeartDrug Research Laboratories, Johns Hopkins University, Baltimore, MD 21204, USA. heartdrug@aol.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |